The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Activate Your Account with an access code or Create a New Account


Rajesh Dash, MD, PhD, Medical & Scientific Director, SSATHI
Cardiologist
Practice Areas
Professional Education
- Board Certification: Cardiovascular Disease, American Board of Internal Medicine (2008)
- Board Certification, Echocardiography, National Board of Echocardiography (2009)
- BS, Stanford University, Biological Sciences (1995)
- Fellowship: UCSF Medical Center (2009) CA
- Medical Education: University of Cincinnati College of Medicine (2002) OH
- PhD, University of Cincinnati MSTP, Pharmacology & Cell Biophysics (2001)
- Internship: University of Washington School of Medicine (2003) WA
- Residency: University of Washington School of Medicine (2005) WA
Honors & Awards
- Chief Cardiology Fellow, UCSF Medical Center (2006-2007)
- Finalist, Young Investigator Award, Society for Cardiovascular Magnetic Resonance (2009)
- Finalist, Young Investigator Award, Basic Science, Northwestern Cardiovascular Forum (2012)
- Finalist, Young Investigators Award, American Heart Association (2008)
- Recipient, Frances & John Bowes Cardiovascular Research Fellowship, UCSF Medical Center (2008-2009)
- Winner, Best Poster Award, ACC Scientific Sessions (2013)
- Winner, Melvin Judkins Young Investigator Award, American Heart Association (2010)
Administrative Appointments
- Co-Director, Falk Cardiovascular MRI Facility (2011 - Present)
- Medical & Scientific Director, Stanford South Asian Translational Heart Initiative (SSATHI) (2013 - Present)
Publications
-
Influence of transgenic overexpression of phospholamban on postextrasystolic potentiation
Hoit, B. D., Tramuta, D. A., Kadambi, V. J., Dash, R., Ball, N., Kranias, E. G., & Walsh, R. A. (1999). Influence of transgenic overexpression of phospholamban on postextrasystolic potentiation. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 31(11), 2007–2015. -
Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: Enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling
Tepe, N. M., Lorenz, J. N., Yatani, A., Dash, R., Kranias, E. G., Dorn, G. W., & Liggett, S. B. (1999). Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: Enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling. BIOCHEMISTRY, 38(50), 16706–16713. -
Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality
Dash, R., Kadambi, V. J., Schmidt, A. G., Tepe, N. M., Biniakiewicz, D., Gerst, M. J., … Kranias, E. G. (2001). Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality. CIRCULATION, 103(6), 889–896. -
The enhanced contractility of the phospholamban-deficient mouse heart persists with aging
Slack, J. P., Grupp, I. L., Dash, R., Holder, D., Schmidt, A., Gerst, M. J., … Kranias, E. G. (2001). The enhanced contractility of the phospholamban-deficient mouse heart persists with aging. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 33(5), 1031–1040.
-
Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium
Dash, R., Frank, K. F., Carr, A. N., Moravec, C. S., & Kranias, E. G. (2001). Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 33(7), 1345–1353.
-
Differential regulation of p38 mitogen-activated protein kinase mediates gender-dependent catecholamine-induced hypertrophy
Dash, R., Schmidt, A. G., Pathak, A., Gerst, M. J., Biniakiewicz, D., Kadambi, V. J., … Kranias, E. G. (2003). Differential regulation of p38 mitogen-activated protein kinase mediates gender-dependent catecholamine-induced hypertrophy. CARDIOVASCULAR RESEARCH, 57(3), 704–714.
-
-
-
-
-
-
-
-
HERPES-SIMPLEX VIRUS VECTOR SYSTEM - ANALYSIS OF ITS IN-VIVO AND IN-VITRO CYTOPATHIC EFFECTS
Ho, D. Y., Fink, S. L., Lawrence, M. S., Meier, T. J., Saydam, T. C., Dash, R., & Sapolsky, R. M. (1995). HERPES-SIMPLEX VIRUS VECTOR SYSTEM - ANALYSIS OF ITS IN-VIVO AND IN-VITRO CYTOPATHIC EFFECTS. JOURNAL OF NEUROSCIENCE METHODS, 57(2), 205–215.
-
HERPES-SIMPLEX VIRUS VECTORS OVEREXPRESSING THE GLUCOSE-TRANSPORTER GENE PROTECT AGAINST SEIZURE-INDUCED NEURON LOSS
Lawrence, M. S., Ho, D. Y., Dash, R., & Sapolsky, R. M. (1995). HERPES-SIMPLEX VIRUS VECTORS OVEREXPRESSING THE GLUCOSE-TRANSPORTER GENE PROTECT AGAINST SEIZURE-INDUCED NEURON LOSS. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 92(16), 7247–7251.
-
A herpes simplex virus vector overexpressing the glucose transporter gene protects the rat dentate gyrus from an antimetabolite toxin
Dash, R., Lawrence, M., Ho, D., & Sapolsky, R. (1996). A herpes simplex virus vector overexpressing the glucose transporter gene protects the rat dentate gyrus from an antimetabolite toxin. EXPERIMENTAL NEUROLOGY, 137(1), 43–48.
-
Overexpression of the glucose transporter gene with a Herpes simplex viral vector protects striatal neurons against stroke
Lawrence, M. S., Sun, G. H., Kunis, D. M., Saydam, T. C., Dash, R., Ho, D. Y., … Steinberg, G. K. (1996). Overexpression of the glucose transporter gene with a Herpes simplex viral vector protects striatal neurons against stroke. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 16(2), 181–185.
-
Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure
Maecker, H., Desai, A., Dash, R., RIVIER, J., Vale, W., & Sapolsky, R. (1997). Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure. BRAIN RESEARCH, 744(1), 166–170.
-
-
-
The contractile and neurohormonal roles of phospholamban in heart failure
Dash, R., & Kranias, E. G. (2003). The contractile and neurohormonal roles of phospholamban in heart failure. Presented at the 17th World Heart Congress, WINNIPEG,CANADA: KLUWER ACADEMIC PUBLISHERS.
-
Relationship between Echocardiographic and Magnetic Resonance Derived Measures of Right Ventricular Size and Function in Patients with Pulmonary Hypertension.
Shiran, H., Zamanian, R. T., McConnell, M. V., Liang, D. H., Dash, R., Heidary, S., … Yang, P. C. (2014). Relationship between Echocardiographic and Magnetic Resonance Derived Measures of Right Ventricular Size and Function in Patients with Pulmonary Hypertension. Journal of the American Society of Echocardiography , 27(4), 405–412.
-
A novel stress echocardiography pattern for myocardial bridge with invasive structural and hemodynamic correlation.
Lin, S., Tremmel, J. A., Yamada, R., Rogers, I. S., Yong, C. M., Turcott, R., … Schnittger, I. (2013). A novel stress echocardiography pattern for myocardial bridge with invasive structural and hemodynamic correlation. Journal of the American Heart Association, 2(2).
-
-
-
Telmisartan in the diabetic murine model of acute myocardial infarction: dual contrast manganese-enhanced and delayed enhancement MRI evaluation of the peri-infarct region.
Toma, I., Kim, P. J., Dash, R., McConnell, M. V., Nishimura, D., Harnish, P., & Yang, P. C. (2016). Telmisartan in the diabetic murine model of acute myocardial infarction: dual contrast manganese-enhanced and delayed enhancement MRI evaluation of the peri-infarct region. Cardiovascular Diabetology, 15(1), 24-?
-
Magnetic Resonance Imaging and Positron Emission Tomography Approaches to Imaging Vascular and Cardiac Inflammation
Amsallem, M., Saito, T., Tada, Y., Dash, R., & McConnell, M. V. (2016). Magnetic Resonance Imaging and Positron Emission Tomography Approaches to Imaging Vascular and Cardiac Inflammation. CIRCULATION JOURNAL, 80(6), 1269–77.
-
Multimodality Molecular Imaging of Cardiac Cell Transplantation: Part II. In Vivo Imaging of Bone Marrow Stromal Cells in Swine with PET/CT and MR Imaging.
Parashurama, N., Ahn, B.-C., Ziv, K., Ito, K., Paulmurugan, R., Willmann, J. K., … Gambhir, S. S. (2016). Multimodality Molecular Imaging of Cardiac Cell Transplantation: Part II. In Vivo Imaging of Bone Marrow Stromal Cells in Swine with PET/CT and MR Imaging. Radiology, 280(3), 826–36.
-
Multimodality Molecular Imaging of Cardiac Cell Transplantation: Part I. Reporter Gene Design, Characterization, and Optical in Vivo Imaging of Bone Marrow Stromal Cells after Myocardial Infarction.
Parashurama, N., Ahn, B.-C., Ziv, K., Ito, K., Paulmurugan, R., Willmann, J. K., … Gambhir, S. S. (2016). Multimodality Molecular Imaging of Cardiac Cell Transplantation: Part I. Reporter Gene Design, Characterization, and Optical in Vivo Imaging of Bone Marrow Stromal Cells after Myocardial Infarction. Radiology, 280(3), 815–25.
-
-
Apelin-13 infusion salvages the peri-infarct region to preserve cardiac function after severe myocardial injury
Chung, W.-J., Cho, A., Byun, K., Moon, J., Ge, X., Seo, H.-S., … Yang, P. C. (2016). Apelin-13 infusion salvages the peri-infarct region to preserve cardiac function after severe myocardial injury. INTERNATIONAL JOURNAL OF CARDIOLOGY, 222, 361–367.
-
An Alpha-1A Adrenergic Receptor Agonist Prevents Acute Doxorubicin Cardiomyopathy in Male Mice
Montgomery, M. D., Chan, T., Swigart, P. M., Myagmar, B.-E., Dash, R., & Simpson, P. C. (2017). An Alpha-1A Adrenergic Receptor Agonist Prevents Acute Doxorubicin Cardiomyopathy in Male Mice. PLOS ONE, 12(1).
-
Therapeutic Hypothermia in Postcardiac Arrest.
Polderman, K. H., Dash, R., Nichol, G., & Deye, N. (2017). Therapeutic Hypothermia in Postcardiac Arrest. Therapeutic Hypothermia and Temperature Management, 7(1), 2–7.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Oct 2017
Very good.
SHC Patient, May 2017
Dr. Dash was wonderful.
SHC Patient, Apr 2017
All was very good as have been all at my prior visits to Stanford TOP NOTCH.
SHC Patient, Jan 2017
Excellent doctor.
SHC Patient, Aug 2016
Dr.Dash has been a life saver.
SHC Patient, Jul 2016
Great again. Again, people GREAT.
SHC Patient, May 2016
Dr. Dash is excellent.
SHC Patient, May 2016
Dr. Dash is wonderful
SHC Patient, May 2016
Dr. Dash was amazing! Highly recommended, caring, and also a type of doctor where I felt he really cared and wanted to help me.
SHC Patient, Mar 2016
Always the best my good recommedation all the time.
SHC Patient, Dec 2015
Dr. Dash is brilliant and makes sure the patient is informed about his/her condition.
SHC Patient, Dec 2015
I absolutely adore Dr. Dash and Dr. Kim. They are so very professional and nice.
SHC Patient, Nov 2015
All good.
SHC Patient, Sep 2015
Dr. Dash is the BEST dr. I have ever had.
SHC Patient, Apr 2015
Excellent breath of knowledge and very _____ with current research and developments for my conditions.
SHC Patient, Apr 2015
I really liked my meeting with Dr. Dash. He was extremely courteous in his advice and I greatly appreciate that.
SHC Patient, Mar 2015
Dr. Dash is amazing. I hope he never leaves SHC!
SHC Patient, Feb 2015
Good experience.
SHC Patient, Feb 2015
I already have referred patients to him.
SHC Patient, Nov 2014
Would not go to a different cardiologist.
SHC Patient, Sep 2014
I really like this doctor! Dr. Dash is very thorough & knows your case & explains everything (complete with drawings & diagrams). He is great!
SHC Patient, Aug 2014
Dr. Dash is the best cardiologist I ever had.
SHC Patient, Aug 2014
Dr. Dash is an exceptional provider in communicating with a patient.
SHC Patient, Feb 2014
Dr. Dash is wonderful.
SHC Patient, Jan 2014
Excellent!

SHC Patient, Oct 2017
Very good.
SHC Patient, May 2017
Dr. Dash was wonderful.
SHC Patient, Apr 2017
All was very good as have been all at my prior visits to Stanford TOP NOTCH.
SHC Patient, Jan 2017
Excellent doctor.
SHC Patient, Aug 2016
Dr.Dash has been a life saver.
SHC Patient, Jul 2016
Great again. Again, people GREAT.
SHC Patient, May 2016
Dr. Dash is excellent.
SHC Patient, May 2016
Dr. Dash is wonderful
SHC Patient, May 2016
Dr. Dash was amazing! Highly recommended, caring, and also a type of doctor where I felt he really cared and wanted to help me.
SHC Patient, Mar 2016
Always the best my good recommedation all the time.
SHC Patient, Dec 2015
Dr. Dash is brilliant and makes sure the patient is informed about his/her condition.
SHC Patient, Dec 2015
I absolutely adore Dr. Dash and Dr. Kim. They are so very professional and nice.
View All 25 Patient Comments »